MedX Health Corp MDX.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 19.44% | 9.88% | -4.83% | 38.17% | 19.16% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.44% | 9.88% | -4.83% | 38.17% | 19.16% |
| Cost of Revenue | 91.18% | 104.86% | 76.05% | 38.09% | 26.75% |
| Gross Profit | -107.95% | -118.65% | -128.12% | 38.50% | 7.79% |
| SG&A Expenses | 40.27% | 41.16% | 84.06% | 31.78% | -2.82% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 41.86% | 40.67% | 66.12% | 26.06% | -0.95% |
| Operating Income | -45.51% | -46.21% | -81.10% | -24.35% | 3.59% |
| Income Before Tax | -31.77% | -37.73% | -68.48% | -63.50% | -18.99% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -31.77% | -37.73% | -68.48% | -63.50% | -18.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -31.77% | -37.73% | -68.48% | -63.50% | -18.99% |
| EBIT | -45.51% | -46.21% | -81.10% | -24.35% | 3.59% |
| EBITDA | -88.24% | -92.11% | -134.92% | -25.40% | 3.51% |
| EPS Basic | -13.93% | -20.00% | -52.00% | -48.89% | 2.40% |
| Normalized Basic EPS | -10.53% | -13.89% | -46.77% | -22.06% | 15.56% |
| EPS Diluted | -13.93% | -20.00% | -52.00% | -48.89% | 2.40% |
| Normalized Diluted EPS | -10.53% | -13.89% | -46.77% | -22.06% | 15.56% |
| Average Basic Shares Outstanding | 15.90% | 15.26% | 11.17% | 10.25% | 16.41% |
| Average Diluted Shares Outstanding | 15.90% | 15.26% | 11.17% | 10.25% | 16.41% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |